SF3B1 mutation is a poor prognostic indicator in luminal B and progesterone receptor-negative breast cancer patients

The purpose of this study was to explore the relationship between SF3B1 mutations and the prognoses of patients with breast cancer. Clinical and SF3B1 mutation data from The Cancer Genome Atlas were analyzed. SF3B1 mutations were evaluated as prognostic factors in all breast cancer patients and spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Xing, Tian, Ming, Gu, Jia, Cheng, Teng, Ma, Ding, Feng, Ling, Xin, Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777750/
https://www.ncbi.nlm.nih.gov/pubmed/29383138
http://dx.doi.org/10.18632/oncotarget.22983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777750/
https://www.ncbi.nlm.nih.gov/pubmed/29383138
http://dx.doi.org/10.18632/oncotarget.22983

Ejemplares similares